It was also reported that a B-ALL patient receiving Kymriah relapsed and died 9 months after achieving complete remission because CD19 CAR-T cells accidentally transduced into leukemic B-cell clones resistant to CAR-T therapy (Ruella et al., 2018). The gene discussed is CD19; the disease is acute lymphoblastic leukemia.